Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice.

ABSTRACT: The video in this section is a copy of a recorded webinar organized by Shionogi to launch cefiderocol to the UK market in September 2020. Dr Andreas Karas presents the key clinical data for this new antibiotic for MDR Gram-negative infections, followed by reflections from Professor Jonathan Edgeworth on the potential use of the new agent in UK clinical practice. Included in the latter is a case study example of a compassionate use case using cefiderocol.

SUBMITTER: Karas JA 

PROVIDER: S-EPMC8251257 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature